The Urine Albumin Creatinine Ratio (UACR) is an important indicator of kidney health that is used by doctors to assess the risk of developing chronic kidney disease (CKD). UACR is a measure of the amount of albumin, a protein, that is present in the urine, relative to the amount of creatinine, a waste product formed in the body. UACR is a useful tool for doctors to identify patients who are at risk for developing CKD, as well as those who may already be in the early stages of the disease.
UACR is a simple test that measures the amount of albumin and creatinine in a person's urine. Albumin is a protein that is normally found in the blood, but can be found in higher concentrations in the urine when the kidneys are not functioning properly. Creatinine is a waste product formed in the body and is normally excreted through the urine. UACR is measured by dividing the amount of albumin present in the urine (measured in milligrams per gram of creatinine) by the amount of creatinine present in the urine (measured in milligrams per gram of creatinine). The result is expressed as a ratio.
UACR is used to detect early signs of kidney damage, as well as to monitor the progression of CKD. UACR can be used to identify patients who are at risk for developing CKD, as well as those who may already be in the early stages of the disease. UACR can also be used to assess the effectiveness of treatments, such as medications or lifestyle changes, that are used to slow the progression of CKD. UACR is also used to monitor patients who have already been diagnosed with CKD to ensure that their kidney function is not deteriorating further.
The normal range for UACR is 0-30 mg/g. A UACR of 30 mg/g or higher is considered abnormal and may indicate the presence of kidney disease. It is important to note that a UACR of 30 mg/g or higher does not necessarily mean that a person has CKD. UACR can be elevated due to other factors, such as dehydration, infection, or certain medications. Therefore, it is important to consult with a doctor to determine the cause of an elevated UACR.
UACR testing is recommended for anyone who is at risk for developing CKD, including those with diabetes, hypertension, or a family history of CKD. Additionally, UACR testing is recommended for anyone who is already diagnosed with CKD, to monitor for any changes in kidney function.
The Urine Albumin Creatinine Ratio (UACR) is an important indicator of kidney health that is used by doctors to assess the risk of developing chronic kidney disease (CKD). UACR is a measure of the amount of albumin, a protein, that is present in the urine, relative to the amount of creatinine, a waste product formed in the body. UACR is a useful tool for doctors to identify patients who are at risk for developing CKD, as well as those who may already be in the early stages of the disease. UACR testing is recommended for anyone who is at risk for developing CKD, including those with diabetes, hypertension, or a family history of CKD. Additionally, UACR testing is recommended for anyone who is already diagnosed with CKD, to monitor for any changes in kidney function.
1.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
2.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
3.
Recurrent UTIs impact eGFR in children with vesicoureteral reflux
4.
Month-Long Wait Times Caused by US Physician Shortage.
5.
Pharyngoesophageal junction cancer is not a good candidate for endoscopically assisted transoral surgery.
1.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
2.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
3.
Leukemia in Focus: Tools, Trials, and Therapy Strategies for Modern Medical Practice
4.
New Research Advances in the Treatment of Multiple Myeloma and Plasmacytoma
5.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation